The total return over the past 12 months is -23.62% vs. +23.67% for the S&P 500. So far it's up -11.53% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (24.37%) | +4.32% | (5.05%) | +11.73% | +14.39% | +11.86% |
| Total Return CAGR | (23.62%) | +5.35% | (4.21%) | +13.01% | +15.86% | +12.93% |
| Revenue CAGR | +9.85% | +10.21% | +12.08% | +11.89% | +10.62% | +11.80% |
| Net Income CAGR | +8.75% | +19.28% | +26.28% | +15.77% | +13.53% | +15.31% |
| EPS CAGR | +6.49% | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | +74.20% | +72.85% | +36.06% | +19.66% | +19.17% | +24.03% |
| Operating Cash Flow CAGR | +80.24% | +65.73% | +33.79% | +19.14% | +17.44% | +18.90% |
| Dividends CAGR | +11.89% | +9.53% | +7.70% | +6.90% | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
ResMed Inc. (RMD)
| Year | Start price | End price | RMD Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $240.87 | $211.94 | (11.53%) | +14.00% | (25.53%) |
| 2025 | $228.69 | $240.87 | +6.26% | +17.72% | (11.46%) |
| 2024 | $172.02 | $228.69 | +34.18% | +24.89% | +9.29% |
| 2023 | $208.13 | $172.02 | (16.53%) | +26.19% | (42.72%) |
| 2022 | $260.48 | $208.13 | (19.47%) | (18.17%) | (1.30%) |
| 2021 | $212.56 | $260.48 | +23.41% | +28.74% | (5.33%) |
| 2020 | $154.97 | $212.56 | +38.34% | +18.37% | +19.97% |
| 2019 | $113.87 | $154.97 | +37.86% | +31.22% | +6.64% |
| 2018 | $84.69 | $113.87 | +36.38% | (4.56%) | +40.94% |
| 2017 | $62.05 | $84.69 | +39.07% | +21.70% | +17.37% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
